France, Germany, Italy, Japan, Spain, UK and US. The majority of Stage 3 NSCLC patients are diagnosed with unresectable tumours, and before approval of Imfinzi in this setting, no new treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback